Cargando…
Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
Lung cancer is the cancer with the highest mortality rate and the highest incidence in the world at this stage. Among them, non-small lung cancer is the most common type of lung cancer, and most small cancers have disappeared, which is the optimal time for surgery at the time of diagnosis. To explor...
Autores principales: | Zhang, Shaofeng, Li, Danqing, Han, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543699/ https://www.ncbi.nlm.nih.gov/pubmed/37791062 http://dx.doi.org/10.1515/biol-2022-0688 |
Ejemplares similares
-
Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical Prognosis of Minimally Invasive Surgery for Lung Cancer
por: Han, Xia, et al.
Publicado: (2022) -
Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
por: Liu, Bo, et al.
Publicado: (2023) -
Influence of PD‐L1 expression on the efficacy of
EGFR‐TKIs in
EGFR
‐mutant non‐small cell lung cancer
por: Lei, Si‐Yu, et al.
Publicado: (2023) -
Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
por: Zhang, Shi-Ling, et al.
Publicado: (2023) -
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
por: Eggermont, Carolien, et al.
Publicado: (2022)